Caxton Associates (New York)
BRKR icon

Caxton Associates (New York)’s Bruker BRKR Stock Holding History

Caxton Associates (New York)’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,950
Closed -$318K – 576
2022
Q1 		$318K Buy
+4,950
New +$338K 0.03% 351
2020
Q4 		– Sell
-10,681
Closed -$425K – 158
2020
Q3 		$425K Buy
+10,681
New +$445K 0.04% 132
2018
Q4 		– Sell
-13,733
Closed -$459K – 295
2018
Q3 		$459K Buy
+13,733
New +$452K 0.03% 246

Other funds holding BRKR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Pallas Capital Advisors
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Caxton Associates (New York)'s BRKR Position: Q2 2022 in Review

Caxton Associates (New York) sold out of Bruker (BRKR) in Q2 2022, closing a stake of 4,950 shares — an estimated $318K sold.

Caxton Associates (New York) first reported a position in BRKR in Q3 2018 and held it in 3 quarters. The position peaked at $459K in Q3 2018. 296 funds tracked by Wall St. Rank hold BRKR as of Q2 2022.

  • Caxton Associates (New York) reported no remaining Bruker position as of Q2 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,950 Bruker shares in Q2 2022, an estimated $318K.
  • Caxton Associates (New York) first reported a position in Bruker in Q3 2018 and held it in 3 quarters.
  • Caxton Associates (New York)'s Bruker position peaked at $459K in Q3 2018.
  • 296 funds tracked by Wall St. Rank held Bruker as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.